Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nan-shan Zhong, MD
The First Affiliated Hospital of Guangzhou Medical University
Study Chair - Wei-jie Guan, PhD
The First Affiliated Hospital of Guangzhou Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Chang-jun Du, MDGuo-jun Zhang, MDJian-ping Zhao, MDJie-ming Qu, MDJin-fu Xu, MDPing Chen, MDQi-chang Lin, MDWei Zhang, MDWei-jie Guan, PhDXiao-nan Tao, MDXing-lin Gao, MDXing-xiang Xu, MDXue-dong Liu, MDYi-jiang Huang, MDYong-hua Gao, PhDYuan-lin Song, MDZong-an Liang, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Oct 2018
- Primary completion
- 30 Apr 2021
- Completion
- 30 Jun 2021
- Last update posted
- 2 Aug 2019
- Registered enrollment
- 350
- Registry id
- NCT03715322
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.